Editorial: The CXCr4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients

被引:6
作者
Noels, Heidi [1 ]
Bernhagen, Juergen [2 ,3 ]
机构
[1] Rhein Westfal TH Aachen, Univ Clin Aachen, Inst Mol Cardiovasc Res IMCAR, D-52062 Aachen, Germany
[2] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Vasc Biol, Munich, Germany
[3] Munich Cluster Syst Neurol SyNergy, Munich, Germany
关键词
cardiovascular diseases; diabetes mellitus; chronic kidney disease; CXCR4; CXCL12/SDF-1; MIF; CD26/DPP4; chemokine; INHIBITORY FACTOR MIF; MYOCARDIAL-INFARCTION; CHEMOKINE; ASSOCIATION; LIGAND;
D O I
10.3389/fimmu.2016.00058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:3
相关论文
共 19 条
[1]  
[Anonymous], 2013, IDF DIABETES ATLAS
[2]   MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment [J].
Bernhagen, Juergen ;
Krohn, Regina ;
Lue, Hongqi ;
Gregory, Julia L. ;
Zernecke, Alma ;
Koenen, Rory R. ;
Dewor, Manfred ;
Georgiev, Ivan ;
Schober, Andreas ;
Leng, Lin ;
Kooistra, Teake ;
Fingerle-Rowson, Guenter ;
Ghezzi, Pietro ;
Kleemann, Robert ;
McColl, Shaun R. ;
Bucala, Richard ;
Hickey, Michael J. ;
Weber, Christian .
NATURE MEDICINE, 2007, 13 (05) :587-596
[3]   A population-based study of the incidence and outcomes of diagnosed chronic kidney disease [J].
Drey, N ;
Roderick, P ;
Mullee, M ;
Rogerson, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) :677-684
[4]  
East Midlands Public Health Observatory (EMPHO) and NHS Kidney Care, 2010, KIDN DIS KEY FACTS F
[5]   Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 [J].
Herder, Christian ;
Illig, Thomas ;
Baumert, Jens ;
Mueller, Martina ;
Klopp, Norman ;
Khuseyinova, Natalie ;
Meisinger, Christa ;
Martin, Stephan ;
Thorand, Barbara ;
Koenig, Wolfgang .
ATHEROSCLEROSIS, 2008, 200 (02) :380-388
[6]   Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants [J].
Kathiresan, Sekar ;
Altschuler, David ;
Anand, Sonia ;
Ardissino, Diego ;
Asselta, Rosanna ;
Ball, Stephen G. ;
Balmforth, Anthony J. ;
Berger, Klaus ;
Berglund, Goran ;
Bernardi, Francesco ;
Bernardinelli, Luisa ;
Berzuini, Carlo ;
Braund, Peter S. ;
Burnett, Mary-Susan ;
Burtt, Noel ;
Cambien, Francois ;
Casari, Giorgio ;
Celli, Patrizia ;
Chen, Zhen ;
Corrocher, Roberto ;
Daly, Mark J. ;
Deloukas, Panos ;
Devaney, Joe ;
Do, Ron ;
Duga, Stefano ;
Elosua, Roberto ;
Engert, James C. ;
Epstein, Stephen E. ;
Erdmann, Jeanette ;
Ferrario, Maurizio ;
Fetiveau, Raffaela ;
Fischer, Marcus ;
Friedlander, Yechiel ;
Gabriel, Stacey B. ;
Galli, Michele ;
Gianniny, Lauren ;
Girelli, Domenico ;
Grosshennig, Anika ;
Guiducci, Candace ;
Hakonarson, Hakon H. ;
Hall, Alistair S. ;
Havulinna, Aki S. ;
Hengstenberg, Christian ;
Hirschhorn, Joel N. ;
Holm, Hilma ;
Huge, Andreas ;
Kent, Kenneth M. ;
Konig, Inke R. ;
Korn, Joshua M. ;
Li, Mingyao .
NATURE GENETICS, 2009, 41 (03) :334-341
[7]   Therapeutic targeting of chemokine interactions in atherosclerosis [J].
Koenen, Rory R. ;
Weber, Christian .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) :141-153
[8]   The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 [J].
Oberlin, E ;
Amara, A ;
Bachelerie, F ;
Bessia, C ;
Virelizier, JL ;
ArenzanaSeisdedos, F ;
Schwartz, O ;
Heard, JM ;
ClarkLewis, I ;
Legler, DF ;
Loetscher, M ;
Baggiolini, M ;
Moser, B .
NATURE, 1996, 382 (6594) :833-835
[9]  
Saran R, 2015, AM J KIDNEY DIS, V66, P545, DOI 10.1053/j.ajkd.2015.05.001
[10]  
Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1161/CIRCGENETICS.111.960443